Individuals with family history of genetic disease at risk of discriminationJune 10, 2009Research: Perceptions of genetic discrimination among people at risk for Huntington's disease: a cross sectional survey, BMJ online People with a family history of genetic disease are often discriminated against by insurance companies and their relatives and friends, according to research published on bmj.com today. Advances in genetic testing have meant that many individuals have been able to tailor treatment and inform reproductive decisions. However, these powerful new technologies have also caused fear about the misuse of genetic information including discrimination, say the authors. Such fear led the US Government to pass legislation preventing health insurance companies and employers using genetic information. The lead authors, Drs Yvonne Bombard and Michael Hayden based at the University of British Columbia, say the scale of genetic discrimination is largely unknown and this is the first study to focus on this issue in a genetically tested and untested population. The authors surveyed 233 individuals in Canada who were at risk of developing Huntington's disease. None of the group had symptoms of the disease, 167 of them underwent testing (83 had the Huntington's disease mutation, 84 did not) and 66 chose not be tested. Huntington's disease is an inherited neurodegenerative psychiatric disorder for which there is no treatment or cure. The disease usually manifests itself in mid-life and individuals suffer from mood and personality changes, chorea (involuntary movements) and cognitive decline. The disease ends in death, usually 15 to 20 years after diagnosis. Around 40% of respondents said they experienced discrimination, primarily by insurance companies (1 in 3), their family and in social settings (1 in 5). Interestingly, there were not many reports of discrimination in employment, health care or public sector settings. The findings show that it is family history that appears to be the major cause of genetic discrimination not participation in genetic testing. The authors conclude that "clearly, there is a need to shift the current focus of genetic discrimination as a genetic testing issue to one that equally highlights the role family history plays in people's lives." The authors maintain that many individuals and families fear being unable to cope with the predictive test results, especially given no treatment exists to slow or prevent Huntington's disease. They add that the decision to test can become a "litmus test by which relatives judge each other's loyalty to the family" and that testing often causes disruption within the family. In conclusion the authors say that "ultimately asymptomatic individuals at genetic risk are at similar risk for discrimination because their label of having a family history of disease." In an accompanying editorial, Professor Aad Tibben from Leiden University in the Netherlands advocates the benefits of genetic testing and says it "gives a person at risk the opportunity to take more responsibility and control over their life, their health and their future. In general, the test brings relief from uncertainty and more control over people's future life, and no serious adverse consequences have been reported." Tibben is intrigued by the study's findings related to genetic discrimination within the family and social relationships and believes more insight is needed into the dynamics in these fields. BMJ-British Medical Journal |
|||||||||||||||||||||
| Related Genetic Disease Current Events and Genetic Disease News Articles 1930s drug slows tumor growth Drugs sometimes have beneficial side effects. A glaucoma treatment causes luscious eyelashes. A blood pressure drug also aids those with a rare genetic disease. 1 shot of gene therapy and children with congenital blindness can now see Born with a retinal disease that made him legally blind, and would eventually leave him totally sightless, the nine-year-old boy used to sit in the back of the classroom, relying on the large print on an electronic screen and assisted by teacher aides. Mice regain ability to extend telomeres suggesting potential for dyskeratosis congenita therapy The human genetic disease dyskeratosis congenita (DKC) is an autosomal dominant disease that leads to abnormalities in tissues with a rapid cell turnover - the skin, nails, bone marrow, lungs and gut. Skin cells may provide early warning for cancer risk elsewhere in body While some scientists have argued that cancer is such a complex genetic disease that you'd have to sequence a person's complete genome in order to predict his or her cancer risk, a University of California, Berkeley, cell biologist suggests that the risk may be more simply determined by inexpensively culturing a few skin cells. Study of huge numbers of genetic mutations point to oxidative stress as underlying cause A study that tracked genetic mutations through the human equivalent of about 5,000 years has demonstrated for the first time that oxidative DNA damage is a primary cause of the process of mutation - the fuel for evolution but also a leading cause of aging, cancer and other diseases. Mutation responsible for cystic fibrosis also involved in muscle atrophy Patients with cystic fibrosis (CF) usually experience significant muscle loss, a symptom traditionally considered to be a secondary complication of the devastating genetic disease. July 23, 2009 Circulating osteogenic precursor (COP) cells form bone in vivo. Bone from Blood: Circulating Cells Form Bone Outside the Normal Skeleton, Penn Study Finds The accepted dogma has been that bone-forming cells, derived from the body's connective tissue, are the only cells able to form the skeleton. Preimplantation genetic diagnosis may pose neurological risks Preimplantation genetic diagnosis (PGD) has helped many couples conceive healthy children and is generally considered a safe practice. New test can detect both genetic and chromosomal abnormalities in embryos One-step screening for both genetic and chromosomal abnormalities has come a stage closer as scientists announced that an embryo test they have been developing has successfully screened cells taken from spare embryos that were known to have cystic fibrosis. Women with cystic fibrosis can have safe and successful fertility treatment Women with cystic fibrosis can have fertility treatment to help them have babies without any long-term adverse effects on either themselves or their children. More Genetic Disease Current Events and Genetic Disease News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||